자하거 약침의 신경정신과 임상 응용에 관한 체계적 문헌 고찰
A Systematic Review of Placenta Pharmacopuncture for Neuropsychiatric Diseases in Practice
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: To perform a systematic review of placenta pharmacopuncture for treating neuropsychiatric diseases, focusing on its efficacy and the safety so that evidence on its clinical use could be obtained, thus contributing to further studies. Methods: Through Korean, English, and Chinese databases (OASIS, Korean TK, KISS, RISS, ScienceON, Pubmed, Cochrane, EMBASE, CINAHL, AMED, CNKI, and Wanfang), combinations of keywords (placenta, pharmacopuncture, etc.) were used to select clinical studies published until January 2021 about placenta pharmacopuncture for neuropsychiatric diseases. Interventions included combined treatments. Study design included cases studies, series, and clinical trials. Cohort studies, literature reviews, in vitro and animal experiments were excluded. The primary outcomes involved measurements of symptoms, Visual Analogue Scale, or questionnaires. Data extracted from databases were imported to Endnote X7 to remove duplicates. The quality of the literature was assessed based on CAse REports Guidelines and Cochrane’s Risk of Bias (ROB). Results: Twenty-one studies were selected, including ten case reports, three case series, two onearmed clinical trials, one non-randomized clinical trial, and five randomized clinical trials. There were six studies on sleep disorders, five studies on stroke sequela, two on mood disorders, two on enuresis, two on Guillain-Barré syndrome, two on multiple sclerosis, one on neurocognitive disorder, and one on vertigo. The most frequent combined treatment was acupuncture in both the experimental group (n=10) and the control group (n=3). Acupoints were ST36, SP6, BL23, CV4, GB20, GV20, N-HN54, and so on. All studies reported improvement of symptoms. The quality of case studies was relatively high. Assessment of ROBs resulted in low risks. Conclusions: Placenta pharmacopuncture is effective for neuropsychiatric diseases such as sleep disorders, mood disorders, enuresis, and neurocognitive disorders. Regarding insomnia, several studies have reported significant improvements with placenta pharmacopuncture. There was no adverse event associated with placenta pharmacopuncture.
Abstract
Objectives: To perform a systematic review of placenta pharmacopuncture for treating neuropsychiatric diseases, focusing on its efficacy and the safety so that evidence on its clinical use could be obtained, thus contributing to further studies. Methods: Through Korean, English, and Chinese databases (OASIS, Korean TK, KISS, RISS, ScienceON, Pubmed, Cochrane, EMBASE, CINAHL, AMED, CNKI, and Wanfang), combinations of keywords (placenta, pharmacopuncture, etc.) were used to select clinical studies published until January 2021 about placenta pharmacopuncture for neuropsychiatric diseases. Interventions included combined treatments. Study design included cases studies, series, and clinical trials. Cohort studies, literature reviews, in vitro and animal experiments were excluded. The primary outcomes involved measurements of symptoms, Visual Analogue Scale, or questionnaires. Data extracted from databases were imported to Endnote X7 to remove duplicates. The quality of the literature was assessed based on CAse REports Guidelines and Cochrane’s Risk of Bias (ROB). Results: Twenty-one studies were selected, including ten case reports, three case series, two onearmed clinical trials, one non-randomized clinical trial, and five randomized clinical trials. There were six studies on sleep disorders, five studies on stroke sequela, two on mood disorders, two on enuresis, two on Guillain-Barré syndrome, two on multiple sclerosis, one on neurocognitive disorder, and one on vertigo. The most frequent combined treatment was acupuncture in both the experimental group (n=10) and the control group (n=3). Acupoints were ST36, SP6, BL23, CV4, GB20, GV20, N-HN54, and so on. All studies reported improvement of symptoms. The quality of case studies was relatively high. Assessment of ROBs resulted in low risks. Conclusions: Placenta pharmacopuncture is effective for neuropsychiatric diseases such as sleep disorders, mood disorders, enuresis, and neurocognitive disorders. Regarding insomnia, several studies have reported significant improvements with placenta pharmacopuncture. There was no adverse event associated with placenta pharmacopuncture.
참고문헌 (56)
- Korean Pharmacopuncture Institute, "Pharmacopuncturology", pp.3~5 (2008), Elsevier Korea
- Shin MS, "Pharmacopuncturology in Musculoskeletal Disease", pp.3~4 (2021), Gaonhae Media
- The Textbook Compilation Committee of Korean Acupuncture and Moxibustion Society, "Acupuncture and Moxibustion Medicine", pp.230~254 (2014), Jipmoondang
- Ju YS, "Woongok Herbal Medicine", pp.1279~1281 (2013), Woosuk Press
- Shin MK, "Clinical Traditional Herbalogy", pp.191~192 (2002), Yeonglimsa
- Carotti D, "An approach to chemical characterization of human placental extracts : proteins, peptides, and amino acids analyses", Physiol Chem Phys, 13(2), pp.129~136 (1981)
- 공미희, "중년기 여성에서 인태반추출물이 갱년기 증상 및 피로도와 심혈관질환 위험인자에 미치는 영향", 박사, 의학, pp.2007
- Park HJ, "Anti-stress effects of human placenta extract : possible involvement of the oxidative stress system in rats", BMC Complement Altern Med, 18(1), pp.149~ (2018)
- 허준, "태반추출물이 인간 연골세포의 증식과 분화에 미치는 영향", Archives of Plastic Surgery, 33(5), pp.616~620 (2006), 대한성형외과학회
- Park JY, "Neuroprotective effect of human placental extract on hypoxic-ischemic brain injury in neonatal rats", Brain Dev, 35(1), pp.68~74 (2013)
- Sur TK, "Anti-inflammatory and anti-platelet aggregation activity of human placental extract", Acta Pharmacol Sin, 24(2), pp.187~192 (2003)
- Jazayeri MH, "Human placental extract attenuates neurological symptoms in the experimental autoimmune encephalomyelitis model of multiple sclerosis-a putative approach in MS disease?", Auto Immun Highlights, 11(1), pp.14~ (2020)
- Lee SK, "The Study on the Hominis Placenta Aqua-acupuncture Solution", Journal of Korean acupuncture & moxibustion medicine society, 17(10), pp.67~74 (2000)
- 허자경, "韓方婦人科 영역에서 紫河車의 효용에 관한 국내외의 연구 동향 고찰", 대한한방부인과학회지, 24(4), pp.85~94 (2011), 대한한방부인과학회
- 이진현, "국내 데이터 베이스 검색을 통한 자하거 약침 시술에 대한 임상 논문고찰", 한방재활의학과학회지, 22(3), pp.79~88 (2012), 한방재활의학과학회
- 유덕우, "Systematic Review of Hominis Placenta Pharmacopuncture in English and Korean Literature", Journal of Acupuncture Research, 34(4), pp.153~158 (2017), 대한침구의학회
- 최수지, "자하거약침의 부인과 질환 임상 연구에 대한 고찰", 대한한방부인과학회지, 32(1), pp.15~25 (2019), 대한한방부인과학회[DOI]
- 송건의, "중국에서의 약침을 활용한 불면증 치료 임상논문 연구동향", 동의신경정신과학회지, 30(3), pp.265~274 (2019), 대한한방신경정신과학회[DOI]
- The Textbook Compilation Committee of Neuropsychiatry of Korean Medicine, "The Neuropsychiatry of Oriental Medicine" (2016), Jipmoondang
- Riley DS, "CARE guidelines for case reports : explanation and elaboration document", J Clin Epidemiol, 89, pp.218~235 (2017)
- Julian Higgins, "Cochrane Handbook for Systematic Reviews of Interventions, Version 6.2" (2021), The Cochrane Collaboration
- Shi XL, "Placental Tissue Fluid Injection at Fengchi Point in the Treatment of Stroke Sequelae(胎盘组织液风池穴注射治疗中风后遗症)", Henan Traditional Chinese Medicine, 21(3), pp.56~57 (2001)
- 노주환, "중풍 환자의 하지 경직에 대한 자하거 약침의 효과 연구", Journal of Pharmacopuncture, 12(4), pp.97~110 (2009), 대한약침학회
- 윤형선, "不眠환자에 대한 紫河車 藥針 효능의 관한 연구", Journal of Acupuncture Research, 21(3), pp.99~106 (2004), 대한침구의학회
- 윤현민, "紫河車 藥鍼이 睡眠障碍에 미치는 效果", Journal of Pharmacopuncture, 8(1), pp.5~12 (2005), 대한약침학회
- Song YJ, "Clinical Observation on Insomnia Syndrome Treated by Acupoint Injection of Placenta Polypeptide Injection (胎盘多肽注射液穴位注射治疗失眠证临床观察)", China Healthcare and Nutrition, 10, pp.296~297 (2012)
- Kong XF, "Observation on the therapeutic effect of acupoint injection combined with acupuncture in the treatment of intractable insomnia (穴位注射配合针刺治疗顽固性失眠疗效观察)", China’s Naturopathy, 25(12), pp.25~ (2017)
- Ling QL, "Clinical Observation on 30 Cases of Pediatric Enuresis Treated by Acupoint Injection of Human Placental Tissue Fluid (穴位注射人胎盘组织液治疗小儿遗尿30例临床观察)", J. Gangsu College of TCM, 28(3), pp.54~56 (2011)
- 김진우, "火病을 紫河車 藥鍼을 使用하여 治療한 1例", 동의신경정신과학회지, 16(1), pp.211~220 (2005), 대한한방신경정신과학회
- 이순이, "産後 憂鬱症을 紫河車 藥鍼을 활용하여 治療한 1例", 대한한방부인과학회지, 19(2), pp.282~294 (2006), 대한한방부인과학회
- 김윤나, "Treatment of Hominis placenta pharmacopuncture for a patient with mild neurocognitive disorder: Case report", Journal of Pharmacopuncture, 22(4), pp.279~283 (2019), 대한약침학회[DOI]
- Kong XF, "10 Cases of Guillain-Barré Syndrome Treated by Injection of Human Placental Tissue Fluid and Electroacupuncture (人胎盘组织液注射加电针治疗格林-巴利综合征10例)", China’s Naturopathy, 21(11), pp.56~ (2013)
- 황규상, "자하거 약침 단독치료로 호전된 다발성 경화증 치험 1례", 대한한방내과학회지, 38(2), pp.289~300 (2017), 대한한방내과학회
- Jang SH, "A Case Report of Vertigo by Korean Medical Treatment with Hominis Placenta Pharmacopunture", Journal of Haehwa Medicine, 25(1), pp.45~52 (2016)
- Wang XT, "Placental tissue fluid injection at Fengchi acupoint cures stroke sequelae (胎盘组织液风池穴注射治愈中风后遗症)", Henan TCM, 15(4), pp.242~ (1995)
- 万静, "Clinical Observation on 35 Cases of Intractable Insomnia Treated by Acupoint Injection(穴位封闭治疗顽固性失眠35例临床观察)", Modern Rehabilitation, 5(8), pp.120~ (2001)
- Yang W, "Mailuoning for acute ischaemic stroke", Cochrane Database Syst Rev, (2), pp.CD007028~ (2009)
- Jang HH, "The Case of regulation of Insomnia with Jahageo Herbal acupuncture", J of Oriental Neuropsychiatry, 14(1), pp.155~160 (2003)
- Ren ZF, "20 Cases of Pediatric Enuresis Treated by Injection of Placental Tissue Fluid and Shenqi Pill Per Os ( 胎盘组织液穴注配合肾气丸内服治疗小儿遗尿20例)", Journal of External Therapy of Traditional Chinese Medicine, 10(6), pp.55~ (2001)
- Heo WY, "A Case Report on Shoulder Pain Caused by Sequela of Cerebral Infarction Treated with Placenta Pharmacopuncture", Journal of the Spine and Joint Korean Medicine, 11(1), pp.97~104 (2014)
- 엄예진, "시상, 중간뇌, 다리뇌 경색에 의한 안구운동장애 치험 1례", 한방안이비인후피부과학회지, 28(4), pp.130~141 (2015), 대한한방안이비인후피부과학회
- Kim DJ, "Guillain-Barre Syndrome Mistaken for a Common Spinal Disorder : A Case Report", Alternative Therapies, 21(3), pp.64~67 (2015)
- Kong XF, "7 Cases of Multiple Sclerosis Treated by Human Placenta Tissue Fluid Injection and Acupuncture(人胎盘组织液注射加针刺治疗多发性硬化7例)", Journal of Frontiers of Medicine, 24, pp.384~385 (2013)
- 박상원, "자하거 약침의 지표물질 선정 및 분석법 벨리데이션", 한방재활의학과학회지, 26(1), pp.33~40 (2016), 한방재활의학과학회
- Lee, Tae-Ho, "Research about the Physical Reactions to Appear in Herbal Acupuncture Operating", Journal of Pharmacopuncture, 6(1), pp.38~46 (2003), 대한약침학회[DOI]
- Kim Y, "Efficacy and safety of Hominis placenta pharmacopuncture on mild cognitive impairment : Randomized, double blind, placebo-controlled, multi-center trial", Medicine(Baltimore), 99(46), pp.e22956~ (2020)
- 박재흥, "말초성 안면신경마비에 대한 약침병행치료 효능의 임상적 고찰 - 자하거 약침과 Sweet Bee Venom을 중심으로 -", Journal of Acupuncture Research, 27(2), pp.79~87 (2010), 대한침구의학회
- 이소열, "자하거 약침의 천식 환자에 대한 연속증례보고", Journal of Pharmacopuncture, 11(4), pp.79~86 (2008), 대한약침학회
- Lee J, "A clinical study of Sanjoincho-induced injection on insomnia patients", J of Oriental Neuropsychiatry, 11(2), pp.79~86 (2000)
- Lee DG, "A Case Report on Patient with Insiomnia Treated with CM Immuno-Pharmacopuncture", Journal of Korea Immuno-Yakchim Society, 6(1), pp.49~59 (2017)
- 서동균, "蟾酥약침이 수면장애 환자의 불면 및 우울 증상에 미치는 영향에 대한 임상적 고찰", Journal of Acupuncture Research, 32(3), pp.175~183 (2015), 대한침구의학회
- Ahn SY, "A Case Report on a Patient with Chronic Insomnia Treated with Hwangryunhaedok-tang Pharmacopuncture", Journal of Korea Immuno-Yakchim Society, 7(1), pp.27~40 (2019)
- 제준태, "뇌졸중 후 우울증에 대한 황련해독탕 약침의 안전성 및 유효성 평가를 위한 임상 시험", Journal of Pharmacopuncture, 13(2), pp.67~74 (2010), 대한약침학회
- 홍민호, "혈관성 치매의 약침 치료에 대한 중의학 임상연구 동향", 동의신경정신과학회지, 31(4), pp.315~327 (2020), 대한한방신경정신과학회[DOI]
- Slim K, "Methodological Index for Non-Randomized Studies:Development and Validation of a New Instrument", ANZ J. Surg, 73, pp.712~716 (2003)
- Page MJ, "The PRISMA 2020 statement : an updated guideline for reporting systematic reviews", BMJ, 372, pp.n71~ (2021)
